Home > Calypso Medical Technologies Salary

Calypso Medical Technologies Salary

  • 53
  • 15
  • 93
Calypso Medical Technologies average salary is $35,000, median salary is $35,000 with a salary range from $35,000 to $35,000.
Calypso Medical Technologies salaries are collected from government agencies and companies. Each salary is associated with a real job position. Calypso Medical Technologies salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
35,000
Average
35,000
Median
35,000
High
35,000
Total 1 Calypso Medical Technologies Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Buisness Development Analyst 35,000-35,000 Chicago, IL, 60601 2011 Calypso Medical Technologies Buisness Development Analyst Salaries (1)
Calypso Medical Technologies Chicago, IL Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Calypso Medical Technologies salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Calypso Medical Technologie... Jobs
CMM Inspector
Calmax Technology Inc. - Santa Clara, CA
Applications Engineer - Nashville, TN
ZEISS International - Nashville, TN
Advanced Engineer Level II - Novi
ZEISS International - Brighton, MI
Advanced Engineer - Level I
ZEISS International - Brighton, MI
See more Calypso Medical Technologies Jobs»
Search All Jobs

JobsOpenHiring – Find open jobs faster
Calypso Medical Techno... Information
  • Calypso Medical Technologies Inc
  • Industry: Medical Equipment
  • City: Seattle, WA
  • Calypso? Medical Technologies, Inc. is a medical device company dedicated to improving the delivery of targeted cancer therapies. Our initial market focus is radiation therapy, a primary approach to treating cancer. In fact, more than one million patients receive radiation treatment annually in the U.S.